Author:
Davison Laura M.,Alberto Andres A.,Dand Hardik A.,Keller Emma J.,Patt Madeline,Khan Ayesha,Dvorina Nina,White Alexandra,Sakurai Nodoka,Liegl Lauren N.,Vogl Thomas,Jorgensen Trine N.
Abstract
Systemic lupus erythematosus (SLE) is an autoimmune disorder disproportionally affecting women. A similar sex difference exists in the murine New Zealand Black/White hybrid model (NZBWF1) of SLE with all females, but only 30-40% of males, developing disease within the first year of life. Myeloid-derived suppressor cells (MDSCs) are prominent in NZBWF1 males and while depletion of these cells in males, but not females, promotes disease development, the mechanism of suppression remains unknown. S100a9, expressed by neutrophils and MDSCs, has previously been shown to exert immunosuppressive functions in cancer and inflammation. Here we investigated if S100a9 exerts immunosuppressive functions in NZBWF1 male and female mice. S100a9+/+, S100a9+/- and S100a9-/- NZBWF1 mice were followed for disease development for up to 8 months of age. Serum autoantibody levels, splenomegaly, lymphocyte activation, glomerulonephritis and proteinuria were measured longitudinally or at the time of harvest. In accordance with an immunosuppressive function of MDSCs in male mice, S100a9-deficient male NZBWF1 mice developed accelerated autoimmunity as indicated by increased numbers of differentiated effector B and T cells, elevated serum autoantibody levels, increased immune-complex deposition and renal inflammation, and accelerated development of proteinuria. In contrast, female mice showed either no response to S100a9-deficiency or even a slight reduction in disease symptoms. Furthermore, male, but not female, S100a9-/- NZBWF1 mice displayed an elevated type I interferon-induced gene signature, suggesting that S100a9 may dampen a pathogenic type I interferon signal in male mice. Taken together, S100a9 exerts an immunosuppressive function in male NZBWF1 mice effectively moderating lupus-like disease development via inhibition of type I interferon production, lymphocyte activation, autoantibody production and the development of renal disease.
Funder
U.S. Department of Defense
Subject
Immunology,Immunology and Allergy
Reference72 articles.
1. Systemic Lupus Erythrematosus;Kotzin,2001
2. Androgen-Induced Immunosuppression;Gubbels Bupp;Front Immunol,2018
3. Testosterone Patches in the Management of Patients with Mild/Moderate Systemic Lupus Erythematosus;Gordon;Rheumatol (Oxford),2008
4. Experience With 19-Nortestosterone in the Therapy of Systemic Lupus Erythematosus: Worsened Disease After Treatment With 19-Nortestosterone in Men and Lack of Improvement in Women;Lahita;J Rheumatol,1992
5. Dehydroepiandrosterone for the Treatment of Systemic Lupus Erythematosus;van Vollenhoven;Expert Opin Pharmacother,2002
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献